| Literature DB >> 30647693 |
Pooja Moteriya1, Hemali Padalia1, Sumitra Chanda1.
Abstract
In this work, we report for the first time, synthesis of silver nanoparticles using Cassia roxburghii leaf extract and evaluate its synergistic antibacterial efficacy and antioxidant potential. The synergistic antimicrobial activity of silver nanoparticles with commercial antibiotics against Gram-positive, Gram-negative bacteria and fungi was evaluated. The antioxidant potential of synthesized silver nanoparticles was evaluated by FRAP and ABTS radical scavenging antioxidant assays. UV-Vis spectra peak at 473 and color change from colorless to brown color confirmed the formation of AgNPs. X-ray diffraction (XRD) and selected area electron diffraction (SAED) pattern confirmed the crystalline nature of synthesized nanoparticles. Transmission electron microscopy (TEM) analysis revealed the average size of particles to be 15-20 nm. Fourier transform infrared spectroscopy (FTIR) revealed the functional groups C. roxburghii leaf that was responsible for the reduction and capping process of nanoparticles. C. roxburghii leaf extract synthesized AgNPs showed good synergistic antimicrobial against Gram-negative bacteria even better than some of the antibiotics used as positive control; they also showed antioxidant potential. The results suggest that the synthesized nanoparticles can be used to treat multidrug resistant microorganisms and stress related diseases and disorders.Entities:
Keywords: Antioxidant activity; Cassia roxburghii; Characterization; Silver nanoparticles; Synergistic antimicrobial activity
Year: 2017 PMID: 30647693 PMCID: PMC6296625 DOI: 10.1016/j.jgeb.2017.06.010
Source DB: PubMed Journal: J Genet Eng Biotechnol ISSN: 1687-157X
Fig. 1(a) Effect of boiling time. (b) Effect of extract amount. (c) Color change in the reaction mixture within 10 min. (d) UV-Visible spectrum of biosynthesized AgNPs at different time interval.
Phytochemical tests of Cassia roxburghii leaf powder.
| Test | Result |
|---|---|
| Flavonoids | ++++ |
| Tannins | +++ |
| Phlobatanins | − |
| Triterpenes | +++ |
| Steroids | − |
| Saponins | − |
| Cardiac glycoside | − |
| Meyer’s | ++ |
| Dragondroff’s | +++ |
| Wagner’s | − |
| Legal’s | − |
Fig. 2FTIR spectrum of biosynthesized AgNPs.
Fig. 3XRD spectrum of biosynthesized AgNPs.
Fig. 4TEM images (a–c) of Ag nanoparticles in low and high magnification, (d) SAED patterns of the silver nanoparticles and (e) EDX spectrum.
Synergistic activity of AgNPs of Cassia roxburghii leaves with different standard antibiotics against Gram-positive bacteria.
| Antibiotic | Increase in fold area | Increase in fold area | ||||
|---|---|---|---|---|---|---|
| Antibiotic(A) | Antibiotic + AgNPs(B) | Antibiotic(A) | Antibiotic + AgNPs(B) | |||
| AMP | – | – | – | 33 ± 1 | 33 ± 0 | 0 |
| PB100 | 11 ± 0 | 11.5 ± 0.5 | 0.09 | 9 ± 0 | 9 ± 0 | 0 |
| Gen10 | 19.5 ± 0.5 | 20.5 ± 0.5 | 0.10 | 16 ± 0 | 16 ± 0 | 0 |
| C30 | 33 ± 1 | 33 ± 1 | 0 | 24 ± 4 | 27 ± 1 | 0.26 |
| P10 | – | – | – | 33 ± 3 | 35 ± 0 | 0.12 |
| Ak10 | 22 ± 2 | 22 ± 1 | 0 | 17 ± 0 | 18 ± 0 | 0.12 |
| TE30 | 27.5 ± 0.5 | 31 ± 1 | 0.27 | 28 ± 0 | 28 ± 0 | 0 |
| CEP30 | 13 ± 1 | 16 ± 2 | 0.51 | 37 ± 0.5 | 37 ± 0 | 0 |
| AMC10 | – | 9 ± 0.5 | 31.5 ± 0.5 | 32 ± 0 | 0.03 | |
| CFP30 | 13.5 ± 0.5 | 14 ± 0 | 0.07 | 24 ± 0 | 27 ± 3 | 0.26 |
| CC10 | 14 ± 0 | 16.5 ± 0.5 | 0.38 | 11.5 ± 0 | 14 ± 0 | 0.48 |
AMP – Ampicillin, PB100 – Polymyxin, Gen10 – Gentamicin, C30 – Chloramphenicol, P10 – Penicillin-G, AK10– Amikacin, TE30 – Tetracycline, CEP30 – Cephalothin, AMC10 – Amoxyclav, CFP30 – Cefpirome, CC10 – Clotrimazole.
Mean surface area of the inhibition zone was calculated for each from the mean diameter. Increase in fold area was calculated as (B2 − A2)/A2, where A and B are the inhibition zones for antibiotics and antibiotics + Ag-NPs, respectively.
Synergistic activity of AgNPs of Cassia roxburghii leaves with different standard antibiotics against Gram-negative bacteria.
| Antibiotic | Increase in fold area | Increase in fold area | ||||
|---|---|---|---|---|---|---|
| Antibiotic(A) | Antibiotic + AgNPs(B) | Antibiotic(A) | Antibiotic + AgNPs(B) | |||
| AMP | 9 ± 0 | 9 ± 0 | 0 | 23 ± 1 | 25 ± 0 | 0.18 |
| PB100 | 9 ± 0 | 9 ± 0 | 0 | 13.5 ± 0.5 | 14.5 ± 0.5 | 0.15 |
| Gen10 | 13.5 ± 1.5 | 16.5 ± 0.5 | 0.49 | 22 ± 1 | 25.5 ± 0.5 | 0.34 |
| C30 | 25.5 ± 2.5 | 27.5 ± 0.5 | 0.16 | 14 ± 1 | 14.5 ± 2.5 | 0.07 |
| P10 | – | – | – | 14 ± 0 | 16 ± 0 | 0.30 |
| Ak10 | 17.5 ± 0.5 | 17.5 ± 0.5 | 0 | 24.5 ± 0.5 | 28 ± 0 | 0.30 |
| TE30 | 22 ± 1 | 27 ± 1 | 0.50 | 26.5 ± 0.5 | 34 ± 1 | 0.64 |
| CEP30 | 10 ± 1.5 | 10 ± 0 | 0 | 11 ± 0 | 11 ± 0 | 0 |
| AMC10 | 9 ± 0 | 9 ± 0 | 0 | 20.5 ± 0.5 | 25 ± 1 | 0.48 |
| CFP30 | 9 ± 0 | 9.5 ± 0.5 | 0.11 | 34 ± 1 | 39 ± 0 | 0.31 |
| CC10 | 12 ± 0± | 17.5 ± 0.5 | 1.1 | – | – | – |
AMP – Ampicillin, PB100 – Polymyxin, Gen10 – Gentamicin, C30 – Chloramphenicol, P10 – Penicillin-G, AK10– Amikacin, TE30 – Tetracycline, CEP30 – Cephalothin, AMC10 – Amoxyclav, CFP30 – Cefpirome, CC10 – Clotrimazole.
Mean surface area of the inhibition zone was calculated for each from the mean diameter. Increase in fold area was calculated as (B2 − A2)/A2, where A and B are the inhibition zones for antibiotics and antibiotics + Ag-NPs, respectively.
Synergistic activity of AgNPs of Cassia roxburghii leaves with different standard antibiotics against fungi.
| Antibiotic | Increase in fold area | Increase in fold area | ||||
|---|---|---|---|---|---|---|
| Antibiotic (A) | Antibiotic + AgNPs (B) | Antibiotic (A) | Antibiotic + AgNPs (B) | |||
| NS100 | 29 ± 1 | 32 ± 0 | 0.21 | 23.5 ± 1.5 | 24.5 ± 0.5 | 0.08 |
| KT30 | 24.5 ± 0.5 | 25 ± 0 | 0.04 | 15.5 ± 0.5 | 17 ± 0 | 0.20 |
| FLC10 | 21.5 ± 1.5 | 24 ± 1 | 0.24 | 13.5 ± 1.5 | 16.5 ± 0.5 | 0.49 |
| AP100 | 15 ± 0 | 16.5 ± 0.5 | 0.21 | 12 ± 0 | 12 ± 0 | 0 |
NS100 – Nystatin, KT30 – Ketoconazole, FLC10 – Fluconazole, AP100 – Amphotericin B.
Mean surface area of the inhibition zone was calculated for each from the mean diameter. Increase in fold area was calculated as (B2 − A2)/A2, where A and B are the inhibition zones for antibiotics and antibiotics + Ag-NPs, respectively.
Synergistic activity of AgNPs of Cassia roxburghii leaves with different standard antibiotics against C. albicans and clinical isolate (44).
| Antifungal | Increase in fold area | Clinical isolate (44) | Increase in fold area | |||
|---|---|---|---|---|---|---|
| Antibiotic (A) | Antibiotic + AgNPs (B) | Antibiotic (A) | Antifungal + AgNPs (B) | |||
| NS100 | 17 ± 0 | 17 ± 0 | 0 | 21 ± 0 | 23.5 ± 1.5 | 0.19 |
| KT30 | 15 ± 0 | 18 ± 0 | 0.44 | – | – | – |
| FLC10 | 20.5 ± 0.5 | 20.5 ± 0.5 | 0 | – | – | – |
| AP100 | 10.5 ± 0.5 | 10.5 ± 0.5 | 0 | 12 ± 0 | 14.5 ± 0.5 | 0.46 |
NS100 – Nystatin, KT30 – Ketoconazole, FLC10 – Fluconazole, AP100 – Amphotericin B.
Mean surface area of the inhibition zone was calculated for each from the mean diameter. Increase in fold area was calculated as (B2 − A2)/A2, where A and B are the inhibition zones for antibiotics and antibiotics + Ag-NPs, respectively.
Fig. 5ABTS radical scavenging activity of AgNPs.